ESMO TAT Asia Congress 2027	291 days
	Advancing cancer drug discovery in Asia together 6/18/2027 - 6/20/2027 Venue: Kerry Hotel, Hong Kong, China
Please note ! All dates are subject to changes.

Connecting Asia-Pacific expertise to accelerate targeted anticancer therapies The ESMO Targeted Anticancer Therapies (TAT) Asia Congress 2027 will bring together leading international and regional experts, emerging researchers, and industry innovators to explore the latest advances in early clinical development of anticancer therapies. The congress will provide a dynamic platform for scientific exchange, focusing on translational research, innovative trial designs, and the development of next-generation targeted therapies in oncology. Why Attend The ESMO TAT Asia Congress is a key meeting for professionals involved in early-phase clinical research and drug development. Attendees will benefit from: Insight into cutting-edge targeted therapies and immunotherapies Updates on first-in-human trials and early clinical data Discussions on biomarker-driven development and precision medicine Opportunities to connect with academic leaders, clinicians, and industry partners A strong focus on the Asia-Pacific oncology landscape and collaboration Join the community driving the future of oncology in Asia-Pacific. Website: https://www.esmo.org/meeting-calendar/esmo-targeted-anticancer-therapies-asia-congress-2027

Organizers
	European Society for Medical Oncology (ESMO)
	Via Ginevra, 4, 6900, Lugano Switzerland Tel: +41-(0)91-973 19 00 http://www.esmo.org/

PC Version	About Us
Showseye - Global Professional Events